UTHR News and Press, United Therapeutics Corporation From 06/05/24

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that Patrick Poisson , Executive Vice President, Technical Operations, will provide an overview and update on the company’s operations during a fireside chat session at the Goldman Sachs ...

2024-06-04 15:35:31 ET More on iShares Russell Mid-Cap ETF: Small and midcap pair trades for every sector - Oppenheimer Seeking Alpha’s Quant Rating on iShares Russell Mid-Cap ETF Dividend scorecard for iShares Russell Mid-Cap ETF Read the full artic...

2024-06-02 10:27:52 ET Summary United Therapeutics is a biotech company with a strong earnings growth and a lead product that contributes over 50% of its revenues. The company has been successful in preventing a competitive product from entering the market, but its options to cont...

2024-05-31 16:28:15 ET More on Liquidia Liquidia Corp.: A Rich Catalyst Path Lies Ahead For Value Unlocking Liquidia Corporation (LQDA) Q1 2024 Earnings Call Transcript Liquidia Corporation (LQDA) Q4 2023 Earnings Call Transcript Liquidia  Q1 2024 Earnin...

2024-05-31 07:42:48 ET Summary 3D Systems is well-positioned to capitalize on the growing bioprinting industry, particularly in the field of 3D organ printing. The company's financials show significant challenges, including negative net income and high levels of debt, which may im...

2024-05-20 13:34:36 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying prioritization. While the media focuses on attaining wealth, that doesn’t mean much if...

2024-05-15 01:22:49 ET Summary MannKind's Q1 revenue rose 63% year-over-year; net income was $10.63 million, reversing a prior loss. Tyvaso DPI, utilizing MannKind’s technosphere technology, continues to capture significant PAH market interest. Despite high current asse...

2024-05-06 14:30:17 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The biotechnology sector is renowned for its potential to deliver groundbreaking medical treatments while offering investors the possibility of significant returns. However, investing in these ...

2024-05-01 14:46:13 ET United Therapeutics Corporation (UTHR) Q1 2024 Earnings Conference Call May 1, 2024 09:00 AM ET Company Participants Dewey Steadman - Head of Investor Relations Martine Rothblatt - Chairperson and Chief Executive Officer Michael Benkowitz -...

2024-05-01 06:37:13 ET More on United Therapeutics United Therapeutics: Neutral Stance On Tyvaso's Patent Challenges And Future Growth Prospects United Therapeutics Corporation (UTHR) Q4 2023 Earnings Call Transcript United Therapeutics Corporation 2023 Q4 - Results ...